January 2025

Schweizer Monat: entrepreneurship series, interview focus on CUTISS

Our CEO Daniela Marino has been featured in a new entrepreneurship series launched by Schweizer Monat, the Swiss monthly magazine. In her video interview, she discusses the challenges and rewards of leading CUTISS and our mission to transform skin surgery with denovoSkin™, the bio-engineered skin graft which promises to grow with the patient, minimize scarring and improve quality of life, particularly for children. Daniela also shares candid insights on what it takes to innovate in the biotech space, the importance of resilience, and how balancing her professional and personal life keeps her grounded. You can watch and listen to the interview, in German, here.   Newsroom Video Interview

Schweizer Monat: entrepreneurship series, interview focus on CUTISS Read More »

Handelszeitung: reportage on the U.S. patient and our latest developments

“The start-up hype of recent years has seen many young entrepreneurs come and go. One who has not only made headlines but also delivered results is Daniela Marino.” Thus reads the opening line of the article published in Switzerland’s business newspaper HandelsZeitung. The article was published on the back of our news in October 2024, announcing the first reconstructive surgery that was done under compassionate use and the first U.S. patient treated with denovoSkin™. Having interviewed Jeremy Goverman M.D. at Massachusetts General Hospital and our CEO Daniela Marino,  the journalist recounts the challenges that we overcame in transporting the personalized skin grafts from Schlieren to Boston, and the wonderful positive outcomes that the surgeons are seeing with the young patient in question. “Daniela and her team are trying to do something that no one else in burn medicine is daring to do. She is developing real skin, not just a substitute,” Jeremy Goverman M.D. is quoted as saying. The link to the article, in German, is available here or on PDF. Newsroom Article (PDF)

Handelszeitung: reportage on the U.S. patient and our latest developments Read More »

Scroll to Top

Newsletter

Would you like to contact us as a journalist?

©WyssZurich

This website uses cookies to ensure you get the best experience on our website.